We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspective on the Use of Radiomics.
- Authors
Khasawneh, Hala; Ferreira Dalla Pria, Hanna Rafaela; Miranda, Joao; Nevin, Rachel; Chhabra, Shalini; Hamdan, Dina; Chakraborty, Jayasree; Biachi de Castria, Tiago; Horvat, Natally
- Abstract
Pancreatic adenocarcinoma (PDAC) is the most common pancreatic cancer and is associated with poor prognosis, a high mortality rate, and a substantial number of healthy life years lost. Surgical resection is the primary treatment option for patients with resectable disease; however, only 10–20% of all patients with PDAC are eligible for resection at the time of diagnosis. In this context, neoadjuvant therapy has the potential to increase the number of patients who are eligible for resection, thereby improving the overall survival rate. For patients who undergo neoadjuvant therapy, computed tomography (CT) remains the primary imaging tool for assessing treatment response. Nevertheless, the interpretation of imaging findings in this context remains challenging, given the similarity between viable tumor and treatment-related changes following neoadjuvant therapy. In this review, following an overview of the various treatment options for PDAC according to its resectability status, we will describe the key challenges regarding CT-based evaluation of PDAC treatment response following neoadjuvant therapy, as well as summarize the literature on CT-based evaluation of PDAC treatment response, including the use of radiomics. Finally, we will outline key recommendations for the management of PDAC after neoadjuvant therapy, taking into consideration CT-based findings.
- Subjects
NEOADJUVANT chemotherapy; COMPUTED tomography; RADIOMICS; IMAGE analysis; PANCREATIC cancer
- Publication
Journal of Clinical Medicine, 2023, Vol 12, Issue 21, p6821
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm12216821